Category Industry Updates

Seek Labs Maps 25 Viral Families via BioSeeker, Advancing Sequence-Directed Antiviral Discovery Model

Seek Labs Maps 25 Viral Families with BioSeeker, Advancing a Sequence-Driven Model for Antiviral Discovery Seek Labs, a private TechBio company focused on developing programmable platforms to decode, program, and ultimately resolve disease mechanisms, has announced a major scientific milestone…

Read MoreSeek Labs Maps 25 Viral Families via BioSeeker, Advancing Sequence-Directed Antiviral Discovery Model

Vertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference

Vertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced new clinical and long-term follow-up data highlighting the expanding impact of its cystic fibrosis (CF) treatment portfolio, particularly ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), across very…

Read MoreVertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference

Teva Presents Real-World Reported Benefits of AUSTEDO® and AUSTEDO XR® in Huntington’s Disease Chorea

Teva Presents New AUSTEDO® and AUSTEDO XR® Data Showing Patient- and Caregiver-Reported Improvements in Huntington’s Disease Chorea Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), has announced new real-world evidence demonstrating that treatment with…

Read MoreTeva Presents Real-World Reported Benefits of AUSTEDO® and AUSTEDO XR® in Huntington’s Disease Chorea

Feinstein Institutes’ John M. Kane Receives 2026 Schizophrenia International Research Society Lifetime Achievement Award

Feinstein Institutes’ John M. Kane Receives 2026 Schizophrenia International Research Society Lifetime Achievement Award John M. Kane, MD, a leading figure in schizophrenia research and co-director of the Institute of Behavioral Science at Northwell Health’s Feinstein Institutes for Medical Research,…

Read MoreFeinstein Institutes’ John M. Kane Receives 2026 Schizophrenia International Research Society Lifetime Achievement Award

Glooko Launches First EHR Integration for Insulin Pump Data Integration into Clinical Workflows

Glooko Launches First-Ever Insulin Pump Settings EHR Integration to Streamline Clinical Workflows and Data Access Glooko, Inc., a global digital health company focused on improving diabetes management and supporting clinicians in addressing glycemic safety across the full continuum of care,…

Read MoreGlooko Launches First EHR Integration for Insulin Pump Data Integration into Clinical Workflows

VB Spine Funds Research to Develop First Predictive Blood Test for Adolescent Scoliosis

VB Spine Partners to Fund Breakthrough Pediatric Scoliosis Genetics Research Led by Dr. Alain Moreau VB Spine LLC, a global, family-owned spine-focused medical company, has announced a strategic partnership to fund advanced research into the molecular genetics of pediatric scoliosis.…

Read MoreVB Spine Funds Research to Develop First Predictive Blood Test for Adolescent Scoliosis

Cellares and TScan Therapeutics Partner to Evaluate Automated Manufacturing of TSC-101 for Hematologic Malignancies

Cellares and TScan Therapeutics Collaborate to Evaluate Automated Manufacturing for TSC-101 TCR-T Therapy in AML and MDS Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company developing T cell receptor-engineered…

Read MoreCellares and TScan Therapeutics Partner to Evaluate Automated Manufacturing of TSC-101 for Hematologic Malignancies

Gilead’s Livdelzi Achieves Significant ALP Normalization in Phase 3 IDEAL Trial for Primary Biliary Cholangitis

Gilead Reports Positive Phase 3 Results for Livdelzi in Primary Biliary Cholangitis, Demonstrating Significant Improvement in Liver Disease Marker Gilead Sciences has announced positive topline results from the Phase 3 IDEAL clinical trial evaluating Livdelzi® (seladelpar) in patients with primary…

Read MoreGilead’s Livdelzi Achieves Significant ALP Normalization in Phase 3 IDEAL Trial for Primary Biliary Cholangitis

Hims & Hers Acquires Eucalyptus to Expand Clinically Supported Weight Management Services in Germany

Hims & Hers Completes Acquisition of Eucalyptus, Strengthening Clinically Supported Weight Management Services in Germany Hims & Hers Health, Inc. has officially completed its acquisition of Eucalyptus, the parent company behind Juniper, marking a significant milestone in the company’s international…

Read MoreHims & Hers Acquires Eucalyptus to Expand Clinically Supported Weight Management Services in Germany

C2N Diagnostics and SouthGenetics Partner to Expand Access to Precivity Across Latin America and the Caribbean

C2N Diagnostics and SouthGenetics Partner to Expand Access to Alzheimer’s Blood Biomarker Testing Across Latin America and the Caribbean C2N Diagnostics, LLC, a specialty diagnostics company focused on advancing blood-based biomarker testing for neurodegenerative diseases, has announced a strategic collaboration…

Read MoreC2N Diagnostics and SouthGenetics Partner to Expand Access to Precivity Across Latin America and the Caribbean